ORAL RITODRINE AND PRETERM PREMATURE RUPTURE OF MEMBRANES

  • 1 January 1985
    • journal article
    • research article
    • Vol. 66  (5) , 621-623
Abstract
A prospective randomized study was performed to determine whether or not oral ritodrine therapy significantly prolonged the latent period in patients with prematurely ruptured membranes. Compared with a control group of similar patients, those treated had a significantly prolonged mean latent period. In addition, 47.6% of the treatment group versus 14.2% of the control group had a latent period of more than one week.